Published in J Thromb Haemost on October 16, 2007
Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet (2010) 2.05
P-selectin 1087G/A polymorphism is associated with neuropsychological test performance in older adults with cardiovascular disease. Stroke (2009) 1.43
The relation of genetic and environmental factors to systemic inflammatory biomarker concentrations. Circ Cardiovasc Genet (2009) 1.19
Soluble P-selectin, SELP polymorphisms, and atherosclerotic risk in European-American and African-African young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arterioscler Thromb Vasc Biol (2008) 1.05
P-selectin and subclinical and clinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis (2015) 0.89
Increased circulating inflammatory endothelial cells in blacks with essential hypertension. Hypertension (2013) 0.87
P-selectin Expression Tracks Cerebral Atrophy in Mexican-Americans. Front Genet (2012) 0.81
ABO blood group associations with markers of endothelial dysfunction in the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis (2016) 0.80
Multi-ethnic analysis reveals soluble L-selectin may be post-transcriptionally regulated by 3'UTR polymorphism: the Multi-Ethnic Study of Atherosclerosis (MESA). Hum Genet (2015) 0.78
Cellular adhesion gene SELP is associated with rheumatoid arthritis and displays differential allelic expression. PLoS One (2014) 0.75
Polymorphisms in the selectin gene cluster are associated with fertility and survival time in a population of Holstein Friesian cows. PLoS One (2017) 0.75
Increased Soluble VCAM-1 and Normal P-Selectin in Cystic Fibrosis: a Cross-Sectional Study. Lung (2017) 0.75
Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med (2001) 10.54
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study. Hypertension (2000) 8.84
The progression from hypertension to congestive heart failure. JAMA (1996) 7.56
Lifetime risk of developing coronary heart disease. Lancet (1999) 7.54
Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation (1997) 7.34
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol (1998) 6.76
Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med (1999) 6.72
Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation (1996) 6.20
Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med (1998) 5.63
Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet (2001) 5.54
Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol (1999) 5.43
Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation (2001) 5.11
Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation (1999) 5.04
Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med (1999) 5.01
Treatment of hypertension with ascorbic acid. Lancet (1999) 4.74
Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med (1994) 4.74
Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet (1998) 4.72
Comparisons of five health status instruments for orthopedic evaluation. Med Care (1990) 4.57
Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation (1994) 4.52
Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol (1998) 4.44
Stroke severity in atrial fibrillation. The Framingham Study. Stroke (1996) 4.11
The carpal tunnel syndrome: diagnostic utility of the history and physical examination findings. Ann Intern Med (1990) 4.02
Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum (1989) 4.02
Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation (1998) 3.89
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study) Am J Cardiol (1992) 3.66
Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell (2006) 3.44
Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation (1994) 3.44
A controlled trial of an educational program to prevent low back injuries. N Engl J Med (1997) 3.33
PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet (1999) 3.22
The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med (1994) 3.20
Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol (1995) 3.19
Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology (2007) 3.12
Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study. Circulation (1996) 3.07
Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int (1999) 2.95
Comparative measurement sensitivity of short and longer health status instruments. Med Care (1992) 2.89
American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. Stroke (1997) 2.87
Antioxidants and atherosclerotic heart disease. N Engl J Med (1997) 2.86
Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. Hypertension (1998) 2.86
Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum (1985) 2.85
Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med (1997) 2.81
Single base mutation in the type II procollagen gene (COL2A1) as a cause of primary osteoarthritis associated with a mild chondrodysplasia. Proc Natl Acad Sci U S A (1990) 2.79
Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med (1997) 2.67
Genetic and environmental contributions to platelet aggregation: the Framingham heart study. Circulation (2001) 2.54
Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study) Am J Cardiol (1999) 2.51
Effect of marathon running on inflammatory and hemostatic markers. Am J Cardiol (2001) 2.50
Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med (1996) 2.49
Secular trends in the prevalence of atrial fibrillation: The Framingham Study. Am Heart J (1996) 2.47
Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation (1996) 2.28
Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol (2000) 2.28
Prognosis after the onset of coronary heart disease. An investigation of differences in outcome between the sexes according to initial coronary disease presentation. Circulation (1993) 2.27
Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. N Engl J Med (1995) 2.26
Statistical methods for polyploid radiation hybrid mapping. Genome Res (1995) 2.15
Distribution and categorization of echocardiographic measurements in relation to reference limits: the Framingham Heart Study: formulation of a height- and sex-specific classification and its prospective validation. Circulation (1997) 2.14
Genetic and non-genetic correlates of vitamins K and D. Eur J Clin Nutr (2007) 2.10
The outcome of decompressive laminectomy for degenerative lumbar stenosis. J Bone Joint Surg Am (1991) 2.09
The association of chronic cough with the risk of myocardial infarction: the Framingham Heart Study. Am J Med (1999) 2.09
Prognostic implications of asymptomatic ventricular arrhythmias: the Framingham Heart Study. Ann Intern Med (1992) 2.08
Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study. Neurology (2007) 2.05
Left ventricular mass and risk of stroke in an elderly cohort. The Framingham Heart Study. JAMA (1994) 2.03
A self-administered hand symptom diagram for the diagnosis and epidemiologic study of carpal tunnel syndrome. J Rheumatol (1990) 1.96
HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells. Proc Natl Acad Sci U S A (2001) 1.89
Iron chelation improves endothelial function in patients with coronary artery disease. Circulation (2001) 1.88
Predicting survival in heart failure case and control subjects by use of fully automated methods for deriving nonlinear and conventional indices of heart rate dynamics. Circulation (1997) 1.87
Blood pressure response during treadmill testing as a risk factor for new-onset hypertension. The Framingham heart study. Circulation (1999) 1.87
Acute hypertriglyceridemia is associated with peripheral vasodilation and increased basal flow in healthy young adults. Am J Cardiol (2001) 1.85
A modification of the Health Assessment Questionnaire for the spondyloarthropathies. J Rheumatol (1990) 1.83
Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA (2000) 1.83
The natural history of borderline isolated systolic hypertension. N Engl J Med (1993) 1.82
Echocardiographic features of the right heart in sleep-disordered breathing: the Framingham Heart Study. Am J Respir Crit Care Med (2001) 1.81
Red blood cell ω-3 fatty acid levels and markers of accelerated brain aging. Neurology (2012) 1.81
Determinants of heart rate variability. J Am Coll Cardiol (1996) 1.79
Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem (1997) 1.77
Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA (1994) 1.71
Differential control of systolic and diastolic blood pressure : factors associated with lack of blood pressure control in the community. Hypertension (2000) 1.70
Association of blood pressure with fibrinolytic potential in the Framingham offspring population. Circulation (2000) 1.70
Epidemiology and significance of atrial fibrillation. Am J Cardiol (1999) 1.68